Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison

BackgroundDue to their favorable physical and biological properties, helium ion beams are increasingly considered a promising alternative to proton beams for radiation therapy. Hence, this work aims at comparing in-silico the treatment of brain and ocular meningiomas with protons and helium ions, using for the first time a dedicated Monte Carlo (MC) based treatment planning engine (MCTP) thoroughly validated both in terms of physical and biological models.MethodsStarting from clinical treatment plans of four patients undergoing proton therapy with a fixed relative biological effectiveness (RBE) of 1.1 and a fraction dose of 1.8 Gy(RBE), new treatment plans were optimized with MCTP for both protons (with variable and fixed RBE) and helium ions (with variable RBE) under the same constraints derived from the initial clinical plans. The resulting dose distributions were dosimetrically compared in terms of dose volume histograms (DVH) parameters for the planning target volume (PTV) and the organs at risk (OARs), as well as dose difference maps.ResultsIn most of the cases helium ion plans provided a similar PTV coverage as protons with a consistent trend of superior OAR sparing. The latter finding was attributed to the ability of helium ions to offer sharper distal and lateral dose fall-offs, as well as a more favorable differential RBE variation in target and normal tissue.ConclusionsAlthough more studies are needed to investigate the clinical potential of helium ions for different tumour entities, the results of this work based on an experimentally validated MC engine support the promise of this modality with state-of-the-art pencil beam scanning delivery, especially in case of tumours growing in close proximity of multiple OARs such as meningiomas.

[1]  Julia Bauer,et al.  Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios , 2016, Radiation oncology.

[2]  K Parodi,et al.  Integration and evaluation of automated Monte Carlo simulations in the clinical practice of scanned proton and carbon ion beam therapy , 2014, Physics in medicine and biology.

[3]  A. Ferrari,et al.  FLUKA: A Multi-Particle Transport Code , 2005 .

[4]  K Parodi,et al.  Data-driven RBE parameterization for helium ion beams , 2016, Physics in medicine and biology.

[5]  D. Hänggi,et al.  Radiobiology of Radiosurgery for the Central Nervous System , 2013, BioMed research international.

[6]  K Parodi,et al.  A Monte Carlo-based treatment planning tool for proton therapy , 2013, Physics in medicine and biology.

[7]  J. Debus,et al.  Helium ions at the heidelberg ion beam therapy center: comparisons between FLUKA Monte Carlo code predictions and dosimetric measurements , 2017, Physics in medicine and biology.

[8]  J. Slabbert,et al.  Assessment of the α/ß ratios for arteriovenous malformations, meningiomas, acoustic neuromas, and the optic chiasma , 2010, International journal of radiation biology.

[9]  K Parodi,et al.  A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation field , 2017, Physics in medicine and biology.

[10]  K Parodi,et al.  Experimental dosimetric comparison of 1H, 4He, 12C and 16O scanned ion beams , 2017, Physics in medicine and biology.

[11]  V. Vlachoudis,et al.  The FLUKA Code: Developments and Challenges for High Energy and Medical Applications , 2014 .

[12]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[13]  Michael Scholz,et al.  Assessment of potential advantages of relevant ions for particle therapy: a model based study. , 2015, Medical physics.

[14]  J. Slabbert,et al.  Stereotactic proton beam therapy of skull base meningiomas. , 2001, International journal of radiation oncology, biology, physics.

[15]  K Parodi,et al.  Dosimetric verification in water of a Monte Carlo treatment planning tool for proton, helium, carbon and oxygen ion beams at the Heidelberg Ion Beam Therapy Center , 2017, Physics in medicine and biology.

[16]  Yunhe Xie,et al.  Prompt Gamma Imaging for In Vivo Range Verification of Pencil Beam Scanning Proton Therapy. , 2017, International journal of radiation oncology, biology, physics.

[17]  H Paganetti,et al.  Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy , 2014, Physics in medicine and biology.

[18]  J. Debus,et al.  Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams , 2016, Oncotarget.

[19]  Bengt K Lind,et al.  A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes , 2013, Acta oncologica.

[20]  A Mairani,et al.  Dosimetric accuracy of a treatment planning system for actively scanned proton beams and small target volumes: Monte Carlo and experimental validation , 2015, Physics in medicine and biology.

[21]  R. Parker.  Particle radiation therapy , 1985, Cancer.

[22]  Katia Parodi,et al.  Clinical implementation of full Monte Carlo dose calculation in proton beam therapy , 2008, Physics in medicine and biology.

[23]  Julia Bauer,et al.  Sensitivity of post treatment positron emission tomography/computed tomography to detect inter-fractional range variations in scanned ion beam therapy , 2017, Acta oncologica.

[24]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[25]  G Kraft,et al.  Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy. , 1999, Physics in medicine and biology.

[26]  O Jäkel,et al.  The Heidelberg Ion Therapy Center. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Katia Parodi,et al.  Phase Space Generation for Proton and Carbon Ion Beams for External Users’ Applications at the Heidelberg Ion Therapy Center , 2016, Front. Oncol..

[28]  Hermann Fuchs,et al.  Can particle beam therapy be improved using helium ions? – a planning study focusing on pediatric patients , 2016, Acta oncologica.

[29]  I. Kaplan,et al.  Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. , 1994, International Journal of Radiation Oncology, Biology, Physics.

[30]  Julia Bauer,et al.  The FLUKA Code: An Accurate Simulation Tool for Particle Therapy , 2016, Front. Oncol..

[31]  Hermann Fuchs,et al.  Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion. , 2015, Medical physics.

[32]  K Parodi,et al.  Biologically optimized helium ion plans: calculation approach and its in vitro validation , 2016, Physics in medicine and biology.

[33]  T. Tessonnier.  Treatment of low-grade meningiomas with protons and helium ions , 2017 .

[34]  K. Parodi,et al.  A Monte Carlo-based treatment-planning tool for ion beam therapy , 2013, Journal of radiation research.

[35]  Harald Paganetti,et al.  Range uncertainty in proton therapy due to variable biological effectiveness. , 2012, Physics in medicine and biology.